Agios Pharm
Price & Volume
Stats
See more52W Range | $22.24-$46 |
Market Cap | $1.6B |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $44.7M |
Revenue Growth (YoY) | 43.7% |
Gross Profit (12 Mos) | -$295.2M |
Diluted EPS | -$7.01 |
News
See moreYahoo Finance • 15 days ago
UiPath, Ramaco Resources And 3 Stocks To Watch Heading Into Wednesday
Yahoo Finance • 17 days ago
Here's Why Shares in Agios Pharmaceuticals Popped Today
Yahoo Finance • 18 days ago
U.S. FDA Approves Agios’ AQVESME™ (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia
Yahoo Finance • last month
Agios Provides Update on U.S. sNDA for Mitapivat in Thalassemia
About
CEO | Mr. Brian M. Goff M.B.A. |
Address | 88 Sidney Street, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 486 |
